Learn More
Ceritinib, MedChemExpress
MedChemExpress Ceritinib (LDK378) is a selective, orally bioavailable, and ATP-competitive ALK tyrosine kinase inhibitor with an IC50 of 200 pM. Ceritinib (LDK378) also inhibits IGF-1R, InsR, and STK22D with IC50 values of 8, 7, and 23 nM, respectively. Ceritinib (LDK378) shows great antitumor potency.
Marca: Medchem Express HY-15656
Descrizione
Ceritinib (LDK378) is a selective, orally bioavailable, and ATP-competitive ALK tyrosine kinase inhibitor with an IC50 of 200 pM. Ceritinib (LDK378) also inhibits IGF-1R, InsR, and STK22D with IC50 values of 8, 7, and 23 nM, respectively. Ceritinib (LDK378) shows great antitumor potency.Specifica
Ceritinib | |
White | |
C28H36ClN5O3S | |
LDK378 | |
CC(C)OC1=CC(C2CCNCC2)=C(C)C=C1NC3=NC=C(Cl)C(NC4=CC=CC=C4S(=O)(C(C)C)=O)=N3 | |
558.14 | |
Research | |
Cancer-Kinase/protease |
1032900-25-6 | |
Research | |
50 mg | |
DMSO : 5.6 mg/mL (10.03 mM; Need ultrasonic) ∣Ethanol : ≥ 3.33 mg/mL (5.97 mM) | |
558.14 | |
97.21% | |
Solid |
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Research purposes only